Biopsy Guidance System Market Incremental Opportunity Assessment till 2028
Biopsy Guidance System Industry Overview The global biopsy guidance system market size is expected to reach USD 1,383.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2021 to 2028. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market. Biopsy Guidance System Market Segmentation Grand View Research has segmented the global biopsy guidance system market on the basis of product, application, end-use, and region: Based on the Product Insights, the market is segmented into Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy. The stereotactic guided biopsy segment held the largest revenue share of 39.7% in 2020 and is expected to witness a considerable growth rate over the forec...